By the same authors

From the same journal

Estimated economic benefits during the 'decade of vaccines' include treatment savings, gains in labor productivity

Research output: Contribution to journalArticle

Standard

Estimated economic benefits during the 'decade of vaccines' include treatment savings, gains in labor productivity. / Stack, Meghan L; Ozawa, Sachiko; Bishai, David M; Mirelman, Andrew; Tam, Yvonne; Niessen, Louis; Walker, Damian G; Levine, Orin S.

In: Health affairs (Project Hope), Vol. 30, No. 6, 06.2011, p. 1021-8.

Research output: Contribution to journalArticle

Harvard

Stack, ML, Ozawa, S, Bishai, DM, Mirelman, A, Tam, Y, Niessen, L, Walker, DG & Levine, OS 2011, 'Estimated economic benefits during the 'decade of vaccines' include treatment savings, gains in labor productivity', Health affairs (Project Hope), vol. 30, no. 6, pp. 1021-8. https://doi.org/10.1377/hlthaff.2011.0382

APA

Stack, M. L., Ozawa, S., Bishai, D. M., Mirelman, A., Tam, Y., Niessen, L., ... Levine, O. S. (2011). Estimated economic benefits during the 'decade of vaccines' include treatment savings, gains in labor productivity. Health affairs (Project Hope), 30(6), 1021-8. https://doi.org/10.1377/hlthaff.2011.0382

Vancouver

Stack ML, Ozawa S, Bishai DM, Mirelman A, Tam Y, Niessen L et al. Estimated economic benefits during the 'decade of vaccines' include treatment savings, gains in labor productivity. Health affairs (Project Hope). 2011 Jun;30(6):1021-8. https://doi.org/10.1377/hlthaff.2011.0382

Author

Stack, Meghan L ; Ozawa, Sachiko ; Bishai, David M ; Mirelman, Andrew ; Tam, Yvonne ; Niessen, Louis ; Walker, Damian G ; Levine, Orin S. / Estimated economic benefits during the 'decade of vaccines' include treatment savings, gains in labor productivity. In: Health affairs (Project Hope). 2011 ; Vol. 30, No. 6. pp. 1021-8.

Bibtex - Download

@article{5b8fc505c23d4febad80026b29559c1b,
title = "Estimated economic benefits during the 'decade of vaccines' include treatment savings, gains in labor productivity",
abstract = "In 2010 the Bill & Melinda Gates Foundation announced a $10 billion commitment over the next ten years to increase access to childhood vaccines in the world's poorest countries. The effort was labeled the {"}Decade of Vaccines.{"} This study estimates both the short- and long-term economic benefits from the introduction and increased use of six vaccines in seventy-two of the world's poorest countries from 2011 to 2020. Increased rates of vaccination against pneumococcal and Haemophilus influenzae type b pneumonia and meningitis, rotavirus, pertussis, measles, and malaria over the next ten years would save 6.4 million lives and avert 426 million cases of illness, $6.2 billion in treatment costs, and $145 billion in productivity losses. Monetary estimates based on this type of analysis can be used to determine the return on investment in immunization from both the international community and local governments, and they should be considered in policy making.",
keywords = "Altruism, Cost Savings, Cost of Illness, Efficiency, Employment, Health Care Costs, Health Services Accessibility, Humans, Immunization Programs, Models, Econometric, Vaccines",
author = "Stack, {Meghan L} and Sachiko Ozawa and Bishai, {David M} and Andrew Mirelman and Yvonne Tam and Louis Niessen and Walker, {Damian G} and Levine, {Orin S}",
year = "2011",
month = "6",
doi = "10.1377/hlthaff.2011.0382",
language = "English",
volume = "30",
pages = "1021--8",
journal = "Health affairs (Project Hope)",
issn = "0278-2715",
publisher = "Project Hope",
number = "6",

}

RIS (suitable for import to EndNote) - Download

TY - JOUR

T1 - Estimated economic benefits during the 'decade of vaccines' include treatment savings, gains in labor productivity

AU - Stack, Meghan L

AU - Ozawa, Sachiko

AU - Bishai, David M

AU - Mirelman, Andrew

AU - Tam, Yvonne

AU - Niessen, Louis

AU - Walker, Damian G

AU - Levine, Orin S

PY - 2011/6

Y1 - 2011/6

N2 - In 2010 the Bill & Melinda Gates Foundation announced a $10 billion commitment over the next ten years to increase access to childhood vaccines in the world's poorest countries. The effort was labeled the "Decade of Vaccines." This study estimates both the short- and long-term economic benefits from the introduction and increased use of six vaccines in seventy-two of the world's poorest countries from 2011 to 2020. Increased rates of vaccination against pneumococcal and Haemophilus influenzae type b pneumonia and meningitis, rotavirus, pertussis, measles, and malaria over the next ten years would save 6.4 million lives and avert 426 million cases of illness, $6.2 billion in treatment costs, and $145 billion in productivity losses. Monetary estimates based on this type of analysis can be used to determine the return on investment in immunization from both the international community and local governments, and they should be considered in policy making.

AB - In 2010 the Bill & Melinda Gates Foundation announced a $10 billion commitment over the next ten years to increase access to childhood vaccines in the world's poorest countries. The effort was labeled the "Decade of Vaccines." This study estimates both the short- and long-term economic benefits from the introduction and increased use of six vaccines in seventy-two of the world's poorest countries from 2011 to 2020. Increased rates of vaccination against pneumococcal and Haemophilus influenzae type b pneumonia and meningitis, rotavirus, pertussis, measles, and malaria over the next ten years would save 6.4 million lives and avert 426 million cases of illness, $6.2 billion in treatment costs, and $145 billion in productivity losses. Monetary estimates based on this type of analysis can be used to determine the return on investment in immunization from both the international community and local governments, and they should be considered in policy making.

KW - Altruism

KW - Cost Savings

KW - Cost of Illness

KW - Efficiency

KW - Employment

KW - Health Care Costs

KW - Health Services Accessibility

KW - Humans

KW - Immunization Programs

KW - Models, Econometric

KW - Vaccines

U2 - 10.1377/hlthaff.2011.0382

DO - 10.1377/hlthaff.2011.0382

M3 - Article

C2 - 21653952

VL - 30

SP - 1021

EP - 1028

JO - Health affairs (Project Hope)

JF - Health affairs (Project Hope)

SN - 0278-2715

IS - 6

ER -